NRx Pharmaceuticals, Inc. (NRXP) Reports In-Line Q3 EPS

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• HSBC Raises S&P500 Target to 8,100
• UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth